SBIR/STTR Research Award

A System for Remote Monitoring of Chronic Lung Disease of Infancy (CLDI)

Award identifier 621b8c2d83ac073ea552592d0e44381f36f4246c44f0b104cfe9ce327d436ad5Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$192,708

Program and phase

SBIR · Phase I

Award year

2012

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ADVANCED MEDICAL ELECTRONICS CORP
Proposal award date
Not reported
Contract end date
Not reported
UEI
GJ1KBJPEZL52
Solicitation number
PA11-096
Topic code
NHLBI

Research abstract

DESCRIPTION (provided by applicant): This proposed project aims to develop technology that facilitates care of infants that are typically in transition from a neonatal intensive care unit (NICU). The focus of this technology is to monitor the conditions associated with chronic lung disease of infancy (CLDI), a group of respiratory diseases that usually evolves from an acute respiratory disorder experienced by a newborn infant. Advances in perinatal care, changes in health care economics, and research suggesting a negative impact of prolonged hospitalization on development of the preterm newborn have influenced discharge practices for infants with CLDI. The home environment has increasingly been recognized as the optimal setting for medically stable, technology assisted infants to receive the complex and demanding care they require. Infants in the NICU are commonly connected to multiple pieces of equipment and monitors. While this lifesaving technology is a necessary part of providing care to these infants, the many wires can also add to the complexity of caring for these infants, particularly in a home environment with untrained personnel. Very recent advances in electronic components allow miniature wireless medical instrumentation to be developed that are ofa size and weight appropriate for a wearable neonate application. The phase I program will develop wireless instrumentation. A clinical study is planned for phase II. PUBLIC HEALTH RELEVANCE: Chronic lung disease of infancy (CLDI) is a group of pulmonary disorders that start in the neonatal period. Often the inciting factor is bronchopulmonary dysplasia (BPD), a chronic condition that usually evolves after premature birth and respiratory distress syndrome due to surfactant deficiency. BPD is the most common pulmonary morbidity in preterm infants and affects approximately 5,000 to 10,000 infants in the United States each year

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

138 SBIR/STTR records share this UEI (1994–2024). Reported award amounts total $61,745,451. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services, Department of Education, National Aeronautics and Space Administration, Department of Homeland Security, Department of Agriculture, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.